InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
6
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Schacht Oliver, Chairman & CEO. Insider active across 1 company, notably OPGEN INC. Aggregated, 9 reports have been published. Breakdown: 6 buys · 0 sell. Total volume traded: €58k. Activity tracked since 10 June 2021. The latest transaction was filed on 31 March 2023 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
12,469 shares0Common StockSEC:0001079973-23-000408:0
1,875 shares0Common StockSEC:0001079973-23-000290:0
38,750 shares0Common StockSEC:0001079973-22-000214:0
10,000 shares@ US$1.49622.9% of flowCommon StockSEC:0001553350-21-001066:0
Canonical exit: 16 Feb 2022 (T+90)
10,000 shares@ US$1.49622.9% of flowCommon StockSEC:0001553350-21-001066
Canonical exit: 16 Feb 2022 (T+90)
5,000 shares@ US$3.0822.6% of flowCommon StockSEC:0001079973-21-000916
Canonical exit: 14 Dec 2021 (T+90)
5,000 shares@ US$3.0822.6% of flowCommon StockSEC:0001079973-21-000916:0
Canonical exit: 14 Dec 2021 (T+90)
1,400 shares@ US$2.224.4% of flowCommon StockSEC:0001079973-21-000524
Canonical exit: 8 Sept 2021 (T+90)
1,400 shares@ US$2.224.4% of flowCommon StockSEC:0001079973-21-000524:0
Canonical exit: 8 Sept 2021 (T+90)
9 of 9 declarations
About Schacht Oliver
Oliver Schacht is the Chief Executive Officer of OPGEN INC. He leads the company with a strategic vision focused on innovation and growth. Under his leadership, OPGEN INC. strives to develop advanced solutions in the healthcare sector. Oliver Schacht is recognized for his ability to navigate complex environments and make informed decisions that promote the long-term success of the company.
